Beta oxidation

Beta oxidation is the mitochondrial process that breaks down fatty acids into acetyl-CoA, and in the bioenergetic framework it is treated not as a neutral alternative fuel pathway but as a fundamental stress signal and a metabolic brake on optimal glucose oxidation. 2 The evolutionary purpose of fatty acid oxidation is to tap into reserves when high-quality food is unavailable, signaling the organism to compensate by turning off energetically expensive functions such as reproduction, cognition, and tissue maintenance. 6 This shift is described as a slow-down system associated with torpor and hibernation, in contrast to the pro-thyroid, structure-renewing oxidation of glucose. 1

Mechanistically, beta oxidation and glucose oxidation are linked through the Randle Cycle, where the products of fat breakdown directly suppress the use of glucose. 2 One product of beta oxidation, malonyl-CoA, specifically inhibits the pyruvate dehydrogenase complex, the enzyme that commits pyruvate from glycolysis into the mitochondria. 2 More broadly, when beta oxidation is highly active, it generates an excess of NADH, lowering the NAD to NADH ratio and placing the cell in a reductive state. 2 Because pyruvate dehydrogenase requires NAD, this reductive state downregulates the enzyme, causing a buildup of pyruvate. The cell then uses pyruvate as an emergency oxidant to regenerate NAD, producing lactic acid as a byproduct. 2 This explains why states of predominant fat oxidation, such as diabetes and cancer, are characterized by elevated lactate and an inability to fully oxidize glucose, which is partially metabolized in the cytosol but stops before entering the Krebs cycle. 3

Excessive beta oxidation is positioned as the prima causa linking stress, diet, and a spectrum of pathologies. 12 Georgi Dinkov has argued that the pathological effects exist on a gradient: the more beta oxidation is increased, the more reductive the cell becomes, driving a progression from mild insulin resistance to diabetes, cardiovascular disease, liver disease, and ultimately cancer. 12 This is because cancer cells produce most of their ATP via beta oxidation, wasting glucose into lactate, and shifting metabolism away from fat oxidation by inhibiting CPT1 with agents like niacinamide or aspirin can force cancer cells to either normalize or undergo apoptosis. 2 Dinkov notes that while aspirin and niacinamide inhibit lipolysis, they only inhibit the beta oxidation process itself in very high, potentially toxic doses; at physiological doses they do not completely block the pathway. 3 The stress hormone cortisol reinforces this pathological shift by increasing fatty acid oxidation and suppressing glucose oxidation, making chronic stress a direct promoter of the beta-oxidation-dominant state. 6

The consequences of a beta-oxidation-dominant metabolism extend to tissue structure and specific disease states. Hair follicles, described as mini-organs, require glucose as their primary fuel and cannot sustain growth on fatty acids or ketones; their function depends on efficient oxidative metabolism producing carbon dioxide, a process that beta oxidation provides less of, thereby slowing the metabolic rate that maintains structural cohesion. 7 Dinkov has highlighted that conditions like pulmonary arterial hypertension and heart failure are driven by dramatically elevated fatty acid oxidation and ketogenesis with concomitantly decreased glucose oxidation, framing them as organ-specific manifestations of stress metabolism or "diabetes of the lungs." 8 Even interventions aimed at weight loss through increased fatty acid oxidation have been shown to decrease insulin sensitivity, leading researchers to conclude that promoting this pathway does not have the desired effect. 11